Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Longduoduo Company Limited

Company price
0.51 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
1000
Market Cap
15.31M

Momentum Score

…

Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases through third-party healthcare service providers, product suppliers, and sales agents. It also provides meridian-regulating and consciousness restoring iatrotechnics; double blood purification; immunological ozonated autohemotherapy; platelet-rich plasma; relaxation therapy; vegetative nerve regulation; and microwave therapy. The company was founded in 2020 and is headquartered in Hohhot, China.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.51
Low
0.51
High
52 Week Price Range
0.51
Low
1.37
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Longduoduo Company Limited (LDDD.US) is quoted on the OTC Pink market and publicly available information does not clearly describe its core operations or financial condition. Major long-term growth drivers are not disclosed, so investors should monitor corporate filings, revenue sources and management credentials; the stock could attract those seeking speculative small-cap exposure if credible business information emerges.

Primary risks include low trading liquidity, minimal regulatory oversight typical of Pink-listed issuers, weak corporate governance and high information and execution risk that increase the likelihood of loss.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.51
Dividend Yield
-
Revenue TTM
2.13M
Revenue Per Share
0.07
Gross Profit TTM
2.11M
Debt / Equity
0.02
ROE
-43.13%
Net Debt
-1.62M
ROCE
55.13%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 0.71M 1.89M 0.03M -7.56M -0.38M
Minority interest -0.03M -0.11M -0.06M 0.05M 0.05M
Net income 0.46M 1.26M -0.04M -7.52M -0.33M
Selling general administrative 3.62M 5.19M 3.20M 9.79M 0.70M
Gross profit 4.17M 7.22M 3.23M 2.23M 0.32M
Reconciled depreciation 0.14M 0.10M 0.07M 0.07M 0.00M
Ebit 0.71M 1.89M - -7.56M -0.38M
Ebitda 0.85M 1.99M - -7.49M -0.38M
Depreciation and amortization 0.14M 0.10M - - -
Operating income 0.55M 2.03M 0.03M -7.56M -0.38M
Other operating expenses 3.71M 5.36M - - -
Tax provision 0.22M 0.52M 0.01M 0.00M 0.00M
Income tax expense 0.22M 0.52M - 0.00M -
Total revenue 4.26M 7.39M 3.82M 3.24M 0.41M
Total operating expenses 3.62M 5.19M 3.79M 10.79M 0.79M
Cost of revenue 0.09M 0.17M 0.59M 1.01M 0.09M
Total other income expense net 0.16M -0.14M 0.00M -0.01M 0.00M
Net income from continuing ops 0.49M 1.36M 0.02M -7.56M -0.38M
Net income applicable to common shares - - - -7.52M -0.33M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 2.13M 2.06M 1.48M 0.61M 0.51M
Other current assets 0.13M 0.12M - 0.03M 0.04M
Total liab 0.83M 1.28M 2.05M 1.63M 0.90M
Total stockholder equity 1.18M 0.70M -0.54M -0.93M -0.33M
Other current liab 0.08M 0.17M 0.13M 1.28M 0.51M
Common stock 0.03M 0.03M - 0.30M 0.16M
Capital stock 0.03M 0.03M 0.03M 0.30M 0.16M
Retained earnings -6.17M -6.63M -7.89M -7.85M -0.33M
Cash 1.64M 1.40M 1.14M 0.36M 0.27M
Total current liabilities 0.83M 1.26M 2.05M 1.63M 0.86M
Current deferred revenue 0.34M 0.71M - - -
Net debt -1.62M -1.37M - - -
Short term debt 0.02M 0.02M - - -
Short long term debt - - - 0.14M -
Short long term debt total 0.02M 0.04M - - -
Other stockholder equity 7.25M 7.25M - 0.02M -0.17M
Property plant equipment - - - 0.19M 0.16M
Total current assets 1.81M 1.66M 1.31M 0.42M 0.36M
Net tangible assets - - - -0.93M -0.33M
Net receivables 0.04M 0.13M - 0.03M 0.04M
Inventory - 0.00M 0.00M 0.00M 0.00M
Accounts payable 0.40M 0.36M 1.04M 0.04M 0.18M
Accumulated other comprehensive income 0.08M 0.06M - - -
Non current assets total 0.31M 0.40M 0.17M 0.19M 0.16M
Capital lease obligations 0.02M 0.04M 0.01M 0.04M 0.09M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -0.06M -0.31M -0.13M -0.11M -0.07M
Change to liabilities - - - 0.24M 0.62M
Total cashflows from investing activities -0.06M -0.31M - -0.11M -0.07M
Net borrowings 0.00M 0.00M - 0.15M 0.15M
Total cash from financing activities 0.00M 0.00M -0.14M 0.18M 0.18M
Change to operating activities - - - 0.49M 0.13M
Net income 0.49M 1.36M -0.04M -7.52M -0.33M
Change in cash 0.24M 0.27M 0.78M 0.08M 0.27M
Begin period cash flow 1.40M 1.14M 0.36M 0.27M 0.00M
End period cash flow 1.64M 1.40M 1.14M 0.36M 0.27M
Total cash from operating activities 0.28M 0.58M 0.97M 0.03M 0.35M
Issuance of capital stock - - 0.00M 0.03M 0.00M
Depreciation 0.14M 0.10M 0.07M 0.07M 0.00M
Change to inventory 0.00M 0.00M 0.00M -0.00M -0.00M
Change to account receivables 0.12M -0.03M - -0.02M -0.04M
Change to netincome - - - 6.78M -0.04M
Capital expenditures 0.06M 0.31M 0.13M 0.11M 0.07M
Change in working capital -0.40M -0.94M 0.43M 0.70M 0.71M
Stock based compensation - 0.00M 0.38M 6.74M 0.00M
Other non cash items 0.04M 0.05M 0.06M 0.09M 0.01M
Free cash flow 0.22M 0.28M 0.84M -0.08M 0.28M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
LDDD
Longduoduo Company Limited
-
-%
0.51 - - 7.18 20.77 6.64 45.50
TMO
Thermo Fisher Scientific Inc
-17.51
2.54%
671.24 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation
-0.25
0.11%
220.36 29.09 28.01 5.67 3.20 6.00 19.09
WUXIF
WuXi AppTec Co. Ltd
-
-%
23.77 22.29 17.95 1.53 5.98 8.39 14.30
WUXAY
WuXi AppTec Co. Ltd
-0.92
3.87%
22.85 23.28 18.73 1.51 6.24 8.39 14.30

Profile*

Longduoduo Company Limited

Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases through third-party healthcare service providers, product suppliers, and sales agents. It also provides meridian-regulating and consciousness restoring iatrotechnics; double blood purification; immunological ozonated autohemotherapy; platelet-rich plasma; relaxation therapy; vegetative nerve regulation; and microwave therapy. The company was founded in 2020 and is headquartered in Hohhot, China.

G3-5-8016 Shui?an Town, Hohhot, China, 010000

86 47 2510 4980

52

Name Title Year Born
Mr. Huibo Xu President & Chairman 1983
Ms. Hongxiao Zhou CEO, Secretary & Director 1976
Ms. Liping Kang Chief Financial Officer 1983

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…